Forsmatini Intermediate
have 0 Relevant products
Fontatinib, The Active Metabolite Of R406, Is A Syk Inhibitor And Ic50 Is 41 Nm. Fontatinib Has Been Approved By The Food And Drug Administration Of The United States For The Treatment Of Chronic Immune Thrombocytopenia (Itp) Since 2018. The Drug Is Orall
